TRAVERE THERAPEUTICS, INC. Other Non-Current Liabilities
TRAVERE THERAPEUTICS, INC. (TVTX) had Other Non-Current Liabilities of $12.07 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-04
- 2026-06-30: Other Liabilities, Noncurrent $12.07M.
- 2026-03-31: Other Liabilities, Noncurrent $9.38M.
- 2025-12-31: Other Liabilities, Noncurrent $7.60M.
- 2025-09-30: Other Liabilities, Noncurrent $5.93M.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $12.07M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $9.38M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $7.60M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $5.93M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $7.88M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $7.27M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $6.80M 10-K · filed 2026-02-19 | |
| 2024-09-30 | $16.29M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $16.64M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $16.38M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $10.32M 10-K · filed 2025-02-21 | $8.48M 10-K · filed 2024-02-20 |
| 2023-09-30 | $8.38M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $8.74M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $9.07M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $9.38M 10-K · filed 2024-02-20 | |
| 2022-09-30 | $9.30M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $9.61M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $10.35M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $12.28M 10-K · filed 2023-02-23 | |
| 2021-09-30 | $43.26M 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $43.73M 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $43.17M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $12.19M 10-K · filed 2022-02-24 | $40.53M 10-K · filed 2021-03-01 |
| 2020-09-30 | $40.33M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $19.51M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $13.31M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $20.89M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $21.49M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $22.10M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $23.41M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $17.55M 10-K · filed 2020-02-24 | $4.50M 10-K · filed 2019-02-26 |
| 2018-09-30 | $4.88M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $4.88M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $4.62M 10-Q · filed 2018-07-06 | |
| 2017-12-31 | $2.47M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $3.81M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $3.85M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $3.86M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $4.01M 10-K · filed 2018-07-06 | |
| 2016-09-30 | $2.46M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $2.55M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $2.89M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $3.07M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $13.91M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $12.15M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $12.29M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $1.62M 10-K · filed 2016-02-26 | $12.23M 10-K · filed 2015-03-11 |
| 2014-09-30 | $12.57M 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |